OTCPK:GWAXF - Post by User
Comment by
Tim2Agamion Apr 30, 2021 5:57pm
222 Views
Post# 33106366
RE:While we all wait for news.
RE:While we all wait for news.xoleSudsburian0 wrote: Maybe should start growing Shrooms in that hole in the idle hole in the ground.
Are you suggesting a joint venture with CYBIN?
Does management need a local source of grow-your-own "boosters for the brain ... to break negative patterns"
Toronto ON-based Cybin Corporation (P.CYBN, Forum) is a medicinal mushroom life sciences company that views psychedelic substances derived from mushrooms as “boosters for the brain” that can potentially rebuild pathways and break negative patterns all while looking at non-psychedelic medical mushroom extracts as the next wave of nutraceuticals that can optimize overall health. Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has selected Alcohol Use Disorder (“AUD”) as the initial target indication for its proprietary deuterated psychedelic tryptamine, CYB003.
AUD is a chronic relapsing brain disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences.